Delisting Determination,The Nasdaq Stock Market, LLC,
September 26, 2016, BIND Therapeutics, Inc. The Nasdaq
Stock Market, Inc. (the Exchange) has determined to remove
from listing the common stock of BIND Therapeutics, Inc.
(the Company), effective at the opening of the trading
session on October 6, 2016. Based on review of information
provided by the Company, Nasdaq Staff determined that the
Company no longer qualified for listing on the Exchange
pursuant to Listing Rules 5110(b) and 5450(b)(1)(A).
The Company was notified of the Staffs determination on
May 2, 2016 and May 10, 2016.  The Company appealed the
determination to a Hearing Panel. On July 28, 2016,
the Company withdrew its request for an appeal.
The Staff determination to delist the Company
became final on August 1, 2016.